(Q47362642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Mario F. Juruena

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Moisés E Bauer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Carmine Pariante

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

3

Anthony J Cleare

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

published in

Acta Neuropsychiatrica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

354-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26983771%20AND%20SRC:MED&resulttype=core&format=json

Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Bone mineral density in women with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Vasoconstrictor response to topical beclomethasone in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Altered glucocorticoid immunoregulation in treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Immunoglobulin production in vitro in major depression: a pilot study on the modulating action of endogenous cortisol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Stress and the progression of the developmental hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Familial aggregation of schizophrenia and schizophrenia spectrum disorders. Evaluation of conflicting results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

The Yin and Yang of nuclear receptors: symposium on nuclear receptors in brain, Oegstgeest, The Netherlands, 13-14 April 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Future therapeutic targets in mood disorders: the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Clinical applications of the dexamethasone suppression test for endogenous depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Treatment of major depression with steroid suppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

The Ernst Schering Poster Award. Intracellular traffic of steroid hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

The DST as a predictor of outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

21 January 2018

Steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Loss of Glucocorticoid Fast Feedback in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Urinary free cortisol in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: Relationships with immune-inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Glucocorticoid resistant syndromes--molecular basis and clinical presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X

Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1601-5215.2003.00051.X